{"id":2996,"date":"2026-05-12T17:57:00","date_gmt":"2026-05-12T17:57:00","guid":{"rendered":"https:\/\/peptilife.co\/?p=2996"},"modified":"2026-05-12T17:57:00","modified_gmt":"2026-05-12T17:57:00","slug":"glow-70-blend-bpc157-ghkcu-tb500-colombia","status":"publish","type":"post","link":"https:\/\/peptilife.co\/en\/glow-70-blend-bpc157-ghkcu-tb500-colombia\/","title":{"rendered":"GLOW 70 in Colombia: blend BPC-157 + GHK-Cu + TB500 - complete guide"},"content":{"rendered":"

The GLOW<\/strong> is a combination of three research peptides with complementary profiles: BPC-157, GHK-Cu and TB500<\/strong>. In its 70 mg total presentation (10 mg BPC-157 + 50 mg GHK-Cu + 10 mg TB500), this blend has generated interest in the research community because of the potential synergies between three molecules with distinct but complementary mechanisms in the processes of regeneration, inflammatory modulation and tissue repair.<\/p>\n

In this complete guide you will find what is the GLOW 70<\/strong>, The content is focused on what each of its components does, what is the scientific logic behind the combination, presentations available in Colombia and reconstitution procedure. All content is focused on research purposes<\/strong>.<\/p>\n\n\n\n

\n\n

Quick summary:<\/strong> GLOW 70 is a blend vial that combines BPC-157 (10 mg) + GHK-Cu (50 mg) + TB500 (10 mg)<\/strong>, 70 mg total. Each component has a different research profile: BPC-157 in gastrointestinal and musculoskeletal repair, GHK-Cu in tissue regeneration, TB500 in healing and angiogenesis. Distributed in Colombia exclusively for scientific research purposes<\/strong>.<\/p>\n\n<\/div><\/div>\n\n\n\n

What is the GLOW 70 blend?<\/h2>\n\n\n\n

The GLOW 70<\/strong> is a formulation that combines in a single vial three research peptides recognized for their mechanisms related to tissue regeneration: BPC-157<\/strong>, GHK-Cu<\/strong> y TB500<\/strong> (also called Thymosin Beta-4 or TB-4). The sum of the three doses (10 + 50 + 10) gives the total 70 mg that give the product its name.<\/p>\n\n\n\n

The concept behind blends in peptide research is not new: combining molecules with complementary mechanisms to study possible synergistic effects on specific cellular processes. In the case of GLOW 70, the three molecules converge on tissue repair but through different pathways: BPC-157 acts mainly on nitric oxide receptors and growth factors; GHK-Cu modulates gene expression and transports copper; TB500 promotes cell migration and the formation of new blood vessels.<\/p>\n\n\n\n

The three components of the GLOW 70<\/h2>\n\n\n\n

BPC-157 (10 mg)<\/h3>\n\n\n\n

The BPC-157<\/strong> (Body Protection Compound) is a 15 amino acid peptide derived from a human gastric protein. It has been studied mainly for its profile in gastrointestinal and musculoskeletal regeneration. Preclinical literature suggests effects on the healing of tendons, ligaments, gastric mucosa and blood vessels. Hundreds of studies have been published since the 1990s.<\/p>\n\n\n\n

GHK-Cu (50 mg)<\/h3>\n\n\n\n

The GHK-Cu<\/strong> is a tripeptide (Glycyl-Histidyl-Lysyl) that forms a natural complex with copper. Researched for more than 50 years for its ability to modulate gene expression related to tissue repair, collagen synthesis and processes associated with cellular aging. It is the major component of GLOW 70 with 50 mg.<\/p>\n\n\n\n

TB500 (10 mg)<\/h3>\n\n\n\n

The TB500<\/strong> (synthetic fragment of Thymosin Beta-4) is a peptide investigated for its role in cell migration, angiogenesis and tissue repair. It is of particular interest in studies on muscle, cardiac and skin injury.<\/p>\n\n\n\n

Why combine all three?<\/h2>\n\n\n\n

The synergistic hypothesis documented in scientific literature points to the fact that these three peptides act on complementary phases of the tissue repair process<\/strong>:<\/p>\n\n\n\n

\n\n
Phase of the process<\/th>Associated main peptide<\/th>Relevant mechanism<\/th><\/tr><\/thead>\n
Initial inflammatory modulation<\/td>BPC-157<\/td>Regulation of inflammatory mediators<\/td><\/tr>\n
Cell migration and angiogenesis<\/td>TB500<\/td>Formation of blood vessels, migration of fibroblasts<\/td><\/tr>\n
Extracellular matrix synthesis<\/td>GHK-Cu<\/td>Collagen synthesis, gene expression of structural proteins<\/td><\/tr>\n
Tissue remodeling<\/td>The three in synergy<\/td>Complementary action on fibroblasts and keratinocytes<\/td><\/tr>\n<\/tbody>\n<\/table><\/figure>\n\n\n\n

It is this theoretical complementarity that justifies research protocols using blends such as GLOW 70 instead of individual peptides.<\/p>\n\n\n\n

Presentation available in Colombia<\/h2>\n\n\n\n

In Peptilife we distribute the blend GLOW GCP157 + GHK-Cu + TB500 (70 mg total)<\/strong><\/a> in lyophilized vial form, ready to reconstitute with bacteriostatic water.<\/p>\n\n\n\n

If you are interested in investigating the components individually, they are also available separately:<\/p>\n\n\n\n